# Exodus Movement, Inc.: financial statements, quarterly

EXOD · NYSE · CIK 1821534 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/exod.md) · [Financials](/companies/exod/financials.md) · [Filings](/companies/exod/filings.md) · [Insiders](/companies/exod/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/exod/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.0](/filings/0000950170-24-125820.md) | [18.5 d](/filings/0000950170-25-034884.md) | [29.1](/filings/0000950170-25-069194.md) | [22.3](/filings/0000950170-25-106553.md) | [20.1](/filings/0001193125-25-274308.md) | [44.8 d](/filings/0001821534-26-000009.md) | [36.0](/filings/0001628280-26-033680.md) | [25.8](/filings/0001628280-26-055453.md) | [30.3](/filings/0001193125-25-274308.md) | [29.4 d](/filings/0001821534-26-000009.md) | [22.7](/filings/0001628280-26-033680.md) | [26.2](/filings/0001628280-26-055453.md) |
| Cost of revenue | $m | [7.7](/filings/0000950170-24-125820.md) | not reported | [10.7](/filings/0000950170-24-060765.md) | [10.8](/filings/0000950170-24-095516.md) | [11.3](/filings/0000950170-24-125820.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [4.2](/filings/0000950170-24-125820.md) | not reported | [18.4](/filings/0000950170-24-060765.md) | [11.5](/filings/0000950170-24-095516.md) | [8.8](/filings/0000950170-24-125820.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(0.7)](/filings/0000950170-24-125820.md) | not reported | [67.1](/filings/0000950170-24-060765.md) | [(14.7)](/filings/0000950170-24-095516.md) | [(0.1)](/filings/0000950170-24-125820.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-055453.md) | not reported | not reported | not reported | [0.3](/filings/0001628280-26-055453.md) |
| Income tax | $m | [0.2](/filings/0000950170-24-125820.md) | [(2.9) d](/filings/0000950170-25-034884.md) | [13.2](/filings/0000950170-25-069194.md) | [(3.9)](/filings/0000950170-25-106553.md) | [0.1](/filings/0001193125-25-274308.md) | [8.5 d](/filings/0001821534-26-000009.md) | [(8.9)](/filings/0001628280-26-033680.md) | [9.8](/filings/0001628280-26-055453.md) | [3.3](/filings/0001193125-25-274308.md) | [(13.5) d](/filings/0001821534-26-000009.md) | [(8.7)](/filings/0001628280-26-033680.md) | [(3.1)](/filings/0001628280-26-055453.md) |
| Net income | $m | [(0.3)](/filings/0000950170-24-125820.md) | [10.4 d](/filings/0000950170-25-034884.md) | [54.8](/filings/0001193125-25-274308.md) | [(9.6)](/filings/0001193125-25-274308.md) | [0.8](/filings/0001193125-25-274308.md) | [66.9 d](/filings/0001821534-26-000009.md) | [(12.9)](/filings/0001628280-26-055453.md) | [37.7](/filings/0001628280-26-055453.md) | [17.0](/filings/0001193125-25-274308.md) | [(53.2) d](/filings/0001821534-26-000009.md) | [(32.1)](/filings/0001628280-26-055453.md) | [(18.6)](/filings/0001628280-26-055453.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.4](/filings/0000950170-24-125820.md) | [11.4](/filings/0000950170-25-034884.md) | [21.0](/filings/0000950170-24-060765.md) | [27.8](/filings/0000950170-24-095516.md) | [26.5](/filings/0000950170-24-125820.md) | [37.9](/filings/0001821534-26-000009.md) | [59.8](/filings/0000950170-25-069194.md) | [52.9](/filings/0000950170-25-106553.md) | [50.5](/filings/0001193125-25-274308.md) | [4.9](/filings/0001628280-26-055453.md) | [72.9](/filings/0001628280-26-033680.md) | [21.2](/filings/0001628280-26-055453.md) |
| Current assets | $m | not reported | [59.7](/filings/0000950170-25-034884.md) | [73.3](/filings/0000950170-24-060765.md) | [76.2](/filings/0000950170-24-095516.md) | [76.9](/filings/0000950170-24-125820.md) | [82.8](/filings/0001821534-26-000009.md) | [79.7](/filings/0000950170-25-069194.md) | [72.6](/filings/0000950170-25-106553.md) | [66.9](/filings/0001193125-25-274308.md) | [99.3](/filings/0001628280-26-055453.md) | [168](/filings/0001628280-26-033680.md) | [397](/filings/0001628280-26-055453.md) |
| Total assets | $m | not reported | [112](/filings/0000950170-25-034884.md) | [225](/filings/0000950170-24-060765.md) | [212](/filings/0000950170-24-095516.md) | [212](/filings/0000950170-24-125820.md) | [288](/filings/0001821534-26-000009.md) | [263](/filings/0000950170-25-069194.md) | [314](/filings/0000950170-25-106553.md) | [338](/filings/0001193125-25-274308.md) | [267](/filings/0001628280-26-055453.md) | [230](/filings/0001628280-26-033680.md) | [597](/filings/0001628280-26-055453.md) |
| Current liabilities | $m | not reported | [7.5](/filings/0000950170-25-034884.md) | [10.8](/filings/0000950170-24-060765.md) | [9.1](/filings/0000950170-24-095516.md) | [9.4](/filings/0000950170-24-125820.md) | [8.3](/filings/0001821534-26-000009.md) | [6.9](/filings/0000950170-25-069194.md) | [11.2](/filings/0000950170-25-106553.md) | [13.7](/filings/0001193125-25-274308.md) | [7.4](/filings/0001628280-26-055453.md) | [11.8](/filings/0001628280-26-033680.md) | [375](/filings/0001628280-26-055453.md) |
| Total liabilities | $m | not reported | [8.0](/filings/0000950170-25-034884.md) | [26.3](/filings/0000950170-24-060765.md) | [20.8](/filings/0000950170-24-095516.md) | [20.5](/filings/0000950170-24-125820.md) | [30.5](/filings/0001821534-26-000009.md) | [21.7](/filings/0000950170-25-069194.md) | [36.6](/filings/0000950170-25-106553.md) | [41.7](/filings/0001193125-25-274308.md) | [19.4](/filings/0001628280-26-055453.md) | [11.8](/filings/0001628280-26-033680.md) | [396](/filings/0001628280-26-055453.md) |
| Shareholders' equity | $m | [93.0](/filings/0000950170-24-125820.md) | [104](/filings/0001821534-26-000009.md) | [199](/filings/0001193125-25-274308.md) | [191](/filings/0001193125-25-274308.md) | [191](/filings/0001193125-25-274308.md) | [258](/filings/0001628280-26-055453.md) | [242](/filings/0001628280-26-055453.md) | [277](/filings/0001628280-26-055453.md) | [297](/filings/0001193125-25-274308.md) | [247](/filings/0001628280-26-055453.md) | [219](/filings/0001628280-26-055453.md) | [201](/filings/0001628280-26-055453.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.9 d](/filings/0000950170-24-125820.md) | [(2.2) d](/filings/0000950170-25-034884.md) | [0.5](/filings/0000950170-25-069194.md) | [(2.4) d](/filings/0000950170-25-106553.md) | [(4.9) d](/filings/0001193125-25-274308.md) | [(5.2) d](/filings/0001821534-26-000009.md) | [(6.2)](/filings/0001628280-26-033680.md) | [(5.3) d](/filings/0001628280-26-055453.md) | [(4.8) d](/filings/0001193125-25-274308.md) | [(9.3) d](/filings/0001821534-26-000009.md) | [(2.6)](/filings/0001628280-26-033680.md) | [(49.5) d](/filings/0001628280-26-055453.md) |
| Capital expenditure | $m | [0.0 d](/filings/0000950170-24-125820.md) | [0.0 d](/filings/0000950170-25-034884.md) | [0.2](/filings/0000950170-25-069194.md) | [0.0 d](/filings/0000950170-25-106553.md) | [0.0 d](/filings/0001193125-25-274308.md) | [0.0 d](/filings/0001821534-26-000009.md) | [0.1](/filings/0001628280-26-033680.md) | [0.1 d](/filings/0001628280-26-055453.md) | [0.0 d](/filings/0001193125-25-274308.md) | [0.1 d](/filings/0001821534-26-000009.md) | [0.0](/filings/0001628280-26-033680.md) | [0.1 d](/filings/0001628280-26-055453.md) |
| Share repurchases | $m | [0.2 d](/filings/0000950170-24-125820.md) | [0.2 d](/filings/0000950170-25-034884.md) | [0.3](/filings/0000950170-25-069194.md) | [0.9 d](/filings/0000950170-25-106553.md) | [1.5 d](/filings/0001193125-25-274308.md) | [2.7 d](/filings/0001821534-26-000009.md) | [5.6](/filings/0001628280-26-033680.md) | [4.2 d](/filings/0001628280-26-055453.md) | [2.9 d](/filings/0001193125-25-274308.md) | [2.3 d](/filings/0001821534-26-000009.md) | [1.3](/filings/0001628280-26-033680.md) | [0.7 d](/filings/0001628280-26-055453.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 9,300,739 at 2025-04-30, from the cover of the [10-Q filed 2025-05-12](/filings/0000950170-25-069194.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.